Related Experiment Video
Updated: Mar 29, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
New Insights in the Diagnosis and Treatment of Heart Failure
Giulio Agnetti1, Massimo F Piepoli2, Giuseppe Siniscalchi3
1Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA ; DIBINEM, University of Bologna, 40126 Bologna, Italy.
Insights
Innovative treatments are being explored for heart failure patients who do not respond to standard therapies and are ineligible for heart transplantation. This review assesses novel diagnostic and therapeutic strategies for end-stage heart disease survivors.
Area of Science:
- Cardiology
- Heart Failure Research
- Transplantation Medicine
Background:
- Cardiovascular disease, particularly ischemic heart disease, is a primary cause of mortality in Western countries.
- Advances in acute coronary syndrome treatment increase survival rates, leading to a rise in heart failure cases.
- Heart transplantation is the gold standard for end-stage heart failure but limited by donor organ availability.
Purpose of the Study:
- To review the safety and efficacy of innovative diagnostic methods for heart failure.
- To evaluate novel therapeutic strategies for patients refractory to standard medical care.
- To assess approaches for patients excluded from cardiac transplantation lists.
Main Methods:
- Literature review of recent studies on advanced heart failure diagnosis.
- Analysis of clinical trial data for innovative heart failure treatments.
- Evaluation of patient outcomes in refractory heart failure cases.
Main Results:
- Emerging diagnostic tools show promise in identifying advanced heart failure.
- Several innovative therapies demonstrate potential benefits for non-transplant candidates.
- Safety profiles of new interventions require further rigorous investigation.
Conclusions:
- Novel approaches offer hope for patients with advanced heart failure ineligible for transplantation.
- Continued research is crucial to validate the efficacy and safety of these innovative strategies.
- Expanding treatment options is vital for improving outcomes in refractory heart failure populations.
Abstract:
Cardiovascular disease is the leading cause of mortality in the US and in westernized countries with ischemic heart disease accounting for the majority of these deaths. Paradoxically, the improvements in the medical and surgical treatments of acute coronary syndrome are leading to an increasing number of "survivors" who are then developing heart failure. Despite considerable advances in its management, the gold standard for the treatment of end-stage heart failure patients remains heart transplantation. Nevertheless, this procedure can be offered only to a small percentage of patients who could benefit from a new heart due to the limited availability of donor organs. The aim of this review is to evaluate the safety and efficacy of innovative approaches in the diagnosis and treatment of patients refractory to standard medical therapy and excluded from cardiac transplantation lists.
Related Concept Videos
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure VII: Nursing Interventions
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Cardiomyopathy V: Interprofessional Care
Rheumatic Heart Disease III: Medical Management

